Log in to save to my catalogue

A novel model for treatment of hypertrophic pachymeningitis

A novel model for treatment of hypertrophic pachymeningitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6414490

A novel model for treatment of hypertrophic pachymeningitis

About this item

Full title

A novel model for treatment of hypertrophic pachymeningitis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Annals of clinical and translational neurology, 2019-03, Vol.6 (3), p.431-444

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
Immunoglobulin (Ig)G4‐related disease is a major cause of hypertrophic pachymeningitis (HP), presenting as a progressive thickening of the dura mater. HP lacks an animal model to determine its underlying mechanisms. We developed a suitable animal model for the treatment of HP.
Methods
We longitudinally evaluated dura in mice with...

Alternative Titles

Full title

A novel model for treatment of hypertrophic pachymeningitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6414490

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6414490

Other Identifiers

ISSN

2328-9503

E-ISSN

2328-9503

DOI

10.1002/acn3.715

How to access this item